Abstract PS5-06: Osteonecrosis of the jaw (ONJ) in patients with metastatic breast cancer treated with denosumab in a randomized phase III trial comparing 4 vs. 12 weekly administration (REDUSE, SAKK 96/12)
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Andreas Müller, Arnoud J Templeton, Stefanie Hayoz, Ursina Zürrer, Ursula Hasler-Strub, Michael Schwitter, Tilly Nothelfer, Konstantin Dedes, Khalil Zaman, Marc Küng, Lorenzo Rossi, Alexander Schreiber, Mathias Fehr, Ulrich Güller, Marcus Vetter, Razvan Popescu, Patrik Weder, Roman Inauen, Catrina Uhlmann Nussbaum, Claudine Egger, Corinne Cescato, Bettina Seifert, David R. Thorn, Corinne Schär, Silke Gillessen, Roger von Moos
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411286636